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Single cell profiling of capillary 
blood enables out of clinic human 
immunity studies
Tatyana Dobreva1,3*, David Brown2,3, Jong Hwee Park2 & Matt Thomson2*
An individual’s immune system is driven by both genetic and environmental factors that vary over 
time. To better understand the temporal and inter-individual variability of gene expression within 
distinct immune cell types, we developed a platform that leverages multiplexed single-cell sequencing 
and out-of-clinic capillary blood extraction to enable simplified, cost-effective profiling of the human 
immune system across people and time at single-cell resolution. Using the platform, we detect 
widespread differences in cell type-specific gene expression between subjects that are stable over 
multiple days.
Increasing evidence implicates the immune system in an overwhelming number of diseases, and distinct cell 
types play specific roles in their  pathogenesis1,44. Studies of peripheral blood have uncovered a wealth of associa-
tions between gene expression, environmental factors, disease risk, and therapeutic  efficacy45,46,48. For example, 
in rheumatoid arthritis, multiple mechanistic paths have been found that lead to disease, and gene expression 
of specific immune cell types can be used as a predictor of therapeutic non-response46. Furthermore, vaccines, 
drugs, and chemotherapy have been shown to yield different efficacy based on time of administration, and such 
findings have been linked to the time-dependence of gene expression in downstream  pathways28,36,47. However, 
human immune studies of gene expression between individuals and across time remain limited to a few cell types 
or time points per subject, constraining our understanding of how networks of heterogeneous cells making up 
each individual’s immune system respond to adverse events and change over time. The advent of single-cell RNA 
sequencing (scRNA-seq) has enabled the interrogation of heterogeneous cell populations in blood without cell 
type isolation and has already been employed in the study of myriad immune-related  diseases1–4. Recent studies 
employing scRNA-seq to study the role of immune cell subpopulations between healthy and ill patients, such 
as those for Crohn’s  disease5,  Tuberculosis6, and COVID-197, have identified cell type-specific disease relevant 
signatures in peripheral blood immune cells; however, these types of studies have been limited to large volume 
venous blood draws which can tax already ill patients, reduce the scope of studies to populations amenable to 
blood draws, and often require larger research teams to handle the patient logistics and sample processing costs 
and labor. In particular, getting repeated venous blood draws within a single day and/or multiple days at the 
subject’s home has been a challenge for older people with frail skin and those on low dosage Acetylsalicylic  acid8. 
This dependence on venous blood dramatically impacts our ability to understand the high temporal dynamics 
of health and disease.
Capillary blood sampling is being increasingly used in point-of-care testing and has been advised for obese, 
elderly, and other patients with fragile or inaccessible  veins9–12. The reduction of patient burden via capillary 
blood sampling could enable researchers to perform studies on otherwise difficult or inaccessible populations, 
and at greater temporal resolution. Additionally, capillary blood is being shown to be comparable to traditional 
venous blood draws for a variety of applications. For example, Catala et al. have shown that 39 out of 45 clini-
cally relevant metabolites had overlapping ranges between capillary blood vs traditional venous blood  draws13, 
and Toma et al. have shown strong correlation (Spearman correlation coefficient ≥ 0.95) between bulk RNA 
sequencing data between capillary and venous blood from the same  donor14. However, to date, scRNA-seq of 
human capillary blood has not yet been validated nor applied to study the immune system. In order to make 
small volumes of capillary blood (100 ul) amenable to scRNA-seq we have developed a platform which consists 
of a painless vacuum-based blood collection device, sample de-multiplexing leveraging commercial genotype 
data, and an analysis pipeline used to identify time-of-day and subject specific genes. The potential of our plat-
form is rooted in enabling large scale studies of immune state variation in health and disease across people. The 
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high-dimensional temporal transcriptome data could be paired with computational approaches to predict and 
understand emergence of pathological immune states. Most importantly, our platform makes collection and 
profiling of human immune cells less invasive, less expensive and as such more scalable than traditional methods 
rooted in large venous blood draws.
Results
Platform for low-cost interrogation of single-cell immune gene expression profiles. Our plat-
form is comprised of a protocol for isolating capillary peripheral blood mononuclear cells (CPBMCs) using a 
touch activated phlebotomy device (TAP)9, pooling samples to reduce per-sample cost using genome-based 
 demultiplexing15, and a computational package that leverages repeated sampling to identify genes that are dif-
ferentially expressed in individuals or between time points, within subpopulations of cells (Fig. 1a). Using a 
painless vacuum-based blood collection device such as the commercial FDA-approved TAP to collect capil-
lary blood makes it convenient to perform at-home self-collected sampling and removes the need for a trained 
phlebotomist, increasing the ease of acquiring more samples. The isolation of CPBMCs is done using gradient 
centrifugation and red blood cells are further removed via a red blood cell lysis buffer. The cells from the different 
subjects are pooled, sequenced via scRNA-seq using a single reagent kit, and  demultiplexed15 via each subject’s 
single-nucleotide polymorphisms (SNPs), reducing the per-sample processing cost. By pooling the data across 
all 6 time points, and using a genotype-free demultiplexing software (popscle), we were able to identify which 
cells belonged to which subject across time points, removing the need for a separate genotyping assay to link 
subjects together across batches.
Single-cell RNA sequencing (scRNA-seq) of low volume capillary blood recovers distinct 
immune cell populations stably across time. As a proof-of-concept, we leveraged our scRNA-seq of 
capillary blood platform to identify genes that exhibit diurnal behavior in subpopulations of cells and find sub-
ject-specific immune relevant gene signatures. We performed a three-day study in which we processed capillary 
Figure 1.  Experimental workflow and consistency of capillary blood sampling. (a) Experimental workflow 
for capillary blood immune profiling. 1. Blood is collected using the TAP device from the deltoid. 2. Capillary 
peripheral blood mononuclear cells (CPBMCs) are separated via centrifugation. 3. Red blood cells are lysed 
and removed, and samples from different subjects are pooled together. 4. Cell transcriptomes are sequenced 
using single-cell sequencing. (b) Time-course study design. CPBMCs are collected and profiled from 4 subjects 
(2 male, 2 female) each morning (AM) and afternoon (PM) for 3 consecutive days. (c) 2-dimensional t-SNE 
projection of the transcriptomes of all cells in all samples. Cells appear to cluster by major cell type (Fig. S6) 
(d) Immune cell type percentages across all samples shows stable cell type abundances (includes cells without 
subject labels). (e) Cell type ratios between capillary blood from this study, and venous blood from 3 other 
studies were the same, with the exception of  CD14+ Monocytes, which are more abundant in venous blood 
(FDR < 0.05, 2-sided student t-test, multiple comparison corrected) The q-values are displayed for each cell type 
comparison.
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blood from four subjects in the morning and afternoon, totaling 24,087 cells across 22 samples (Fig. 1b). Major 
immune cell types such as T cells  (CD4+,  CD8+), Natural Killer cells, Monocytes  (CD14+,  CD16+), and B cells are 
present in all subjects and time points with stable expression of key marker genes (Fig. 1d, Fig. S1), demonstrat-
ing that these signals are robust to technical and biological variability of CPBMC sampling (Fig. 1c). In order to 
compare cell type distributions derived from our method with venous blood draws, we used data from 11 healthy 
subjects provided by three independent  studies7,16,17 (Table S4).  CD14+ Monocytes make up a higher percentage 
of PBMCs in venous blood (n = 11) versus capillary blood (n = 22) (FDR < 0.05, 2-sided student t-test, multiple 
comparison corrected), while other cell types do not have a significant difference in distributions (Fig. 1e).
High frequency scRNA-seq unveils new diurnal cell type-specific genes. Genes driven by time-
of-day expression, such as those involved in leukocyte  recruitment18 and regulation of oxidative  stress19, have 
been determined to play an important role in both innate and adaptive immune  cells20. Medical conditions 
such as atherosclerosis, parasite infection, sepsis, and allergies display distinct time-of-day immune responses in 
 leukocytes21, suggesting the presence of diurnally expressing genes that could be candidates for optimizing ther-
apeutic efficacy via time-of-day dependent administration. However, studies examining diurnal gene expression 
in human blood have been limited to whole blood gene panels via qPCR, or bulk RNA-seq22–24.
Leveraging our platform, which enables single-cell studies of temporal human immune gene expression, we 
detected 395 genes (FDR < 0.05, multiple comparison corrected) exhibiting diurnal activity within at least one 
cell subpopulation (Fig. 2a). Among the 20 top diurnally classified genes, we found that 35% of those genes were 
previously correlated with circadian behavior (Table S1), such as  DDIT422 (Fig. 2b),  SMAP225, and  PCPB126. 
However, only 119/395 (30.1%) of these genes are detected as diurnal at the whole population level (FDR < 0.05, 
multiple comparison corrected), suggesting there may be many more diurnally-varying genes than previously 
discovered. For example, IFI16 and LSP1 (Fig. 2c) have diurnal expression only in NK cells and B cells, respec-
tively, and display previously unreported transcriptional diurnal patterns. In particular, LSP1 has been impli-
cated in numerous leukemias and lymphomas of B cell  origin27. Given previous evidence of increased efficacy of 
time-dependent chemotherapy  administration28,29 and tumor cells exhibiting out-of-sync behavior compared to 
normal  cells30, understanding LSP1’s diurnal expression pattern can potentially guide timely administration of 
candidate therapeutics. Out of the identified 395 diurnally-varying genes, 114 (29%) are considered druggable 
under the drug gene interaction database (https ://www.dgidb .org/).
Figure 2.  Diurnal variability in subpopulations of capillary blood (a) Magnitude (Z-score) of the difference in 
AM vs PM gene expression across the whole population of cells (x) vs the cell type with the largest magnitude 
Z-score (y). Points above or below the significance lines (FDR < 0.05, multiple comparison correction) display 
different degrees of diurnality. The size of each marker indicates the abundance of the gene (the largest percent 
of cells in a subpopulation that express this gene). (b) Distribution of expression of DDIT4, a previously 
identified circadian rhythm  gene22, shows diurnal signal across all cells, as well as individual cell types, 
such as natural killer (NK) cells. u indicates the mean fraction of transcripts per cell (gene abundance). (c) 
Example of newly identified diurnal genes, LSP1 and IFI16 that could be missed if analyzed at the population 
level (d) Example of a gene, EAF2, that could be falsely classified as diurnal (i) without considering cell type 
subpopulations due to a diurnal B cell abundance shift (ii).
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scRNA-seq profiling distinguishes diurnal gene expression from cell type abundance 
changes. We also detected 406 genes (FDR < 0.05, multiple comparison corrected) exhibiting diurnal behav-
ior when analyzed at the population level, such as EAF2, that do not display diurnal variation in any of our major 
cell types (Fig. 2d.i). Such false positives may come from diurnal shifts in cell type abundance rather than up- or 
down-regulation of genes. In the case of EAF2, which is most abundant in B cells, we hypothesized that the 
diurnality detected at the population level was a result of an increase of B cell abundance in the afternoon, and 
verified this in our data (p = 7.5 × 10–3, one-sided student-t test) (Fig. 2d.ii). This finding highlights the impor-
tance of looking at expression within multiple cell types to avoid potentially misleading mechanistic hypotheses.
Individuals exhibit robust cell type-specific differences in genes and pathways relevant to 
immune function. Gene expression studies of isolated cell subpopulations across large cohorts of people 
have revealed a high degree of variability between individuals that cannot be accounted for by genetics alone, 
with environmental effects that vary over time likely playing a critical  role31,32. Furthermore, these transcriptomic 
differences have been linked to a wide range of therapeutic responses, such as drug-induced  cardiotoxicity33. 
However, while immune system composition and expression has been shown to be stable over long time periods 
within an individual, acute immune responses generate dramatic immune system changes, meaning that large 
single time point population studies are unable to establish whether variability between individuals is stable or 
the result of dynamic response to  stimuli34.
To probe the stability of individual gene expression signatures at the single-cell level, we used our pipeline 
to identify genes whose variation in gene expression is most likely caused by intrinsic intersubject differences 
rather than high frequency immune system variability. We compared the mean gene expressions of all time points 
between subjects in all cell types and identified 1284 genes (FDR < 0.05, multiple comparison corrected) that are 
differentially expressed in at least one subpopulation of cells. Like Whitney et al., we found MHC class II genes, 
such as HLA-DRB1 and HLA-DRA (Fig. 3a) to be among the largest sources of variation between  subjects35. 
Additionally, we found that DDX17, which was classified by Whitney et al. as a gene with high intersubject 
variability, but low intrasubject variability via repeat sampling over longer time scales, may be a new class of 
temporally varying gene that varies by day of week, having consistently increasing expression each subsequent 
sampling day. This stresses the importance of high frequency sampling for identifying genes with the most 
intrinsic interindividual variability.
Numerous subject-specific genes are revealed in specific immune cell types. Within the 1284 
genes with intrinsic interindividual variability, we found myriad disease-relevant genes for all subjects and cell 
types, which can be explored at our interactive online portal (https ://capbl ood-seq.calte ch.edu). As just one 
example, subject S1’s monocytes have a consistent downregulation (p = 9.1 × 10–7, two-sided student t-test) of 
LIPA, a gene that is implicated in Lysosomal Acid Lipase Deficiency (Fig.  3c). Given the low abundance of 
monocytes in blood samples, such findings would typically only be discovered from a targeted blood test or RNA 
sequencing of isolated monocytes, either of which would only be performed if the disease was already suspected; 
this showcases how automated discovery in heterogeneous cell populations can be leveraged for personalized, 
preventative care.
Immune function and disease pathways are enriched in subject-specific genes. Given that 
genes do not act alone, we also found cell type-specific pathway differences among subjects. In particular, Sub-
ject 2’s S100A8, S100A9, and S100A12 genes, calcium-binding proteins that play an important role in mac-
rophage inflammation, are significantly downregulated in monocytes  (pS100A8 = 1.3 × 10–5,  pS100A9 = 9.0 × 10–5, 
 pS100A12 = 3.0 × 10–4, two-sided student t-test) compared to other subjects (Fig. S2). We further explored our find-
ings by inspecting the pathways that are most enriched in individual and time-varying genes, and found that 
genes that are implicated in immune system function (p = 0.085) and immune diseases (p = 0.029) are more 
present in subject-specific genes (Fig. 3b). This stands in contrast to pathways of core cellular functions such as 
genetic information processing (p = 0.029) and metabolism (p = 0.095), which are less present in subject-specific 
genes.
Discussion. Genome and transcriptome sequencing projects have unveiled millions of genetic variants and 
associated gene expression traits in  humans37,38. However, large-scale studies of their functional effects per-
formed through venous blood draws require tremendous effort to undertake, and this is exacerbated by the cost 
and complexity of single-cell transcriptome sequencing. Efforts such as the Immune Cell  Census39 are already 
underway to perform single-cell profiling of large cohorts, but reliance on venous blood draws of PBMCs will 
likely limit the diversity and temporal resolution of their sample pool. Our platform gives researchers direct, 
scalable access to high resolution immune system transcriptome information of human subjects, lowering the 
barrier of entry for myriad new research avenues. Examples of such studies include: 1. tracking vulnerable popu-
lations over time, such as monitoring clonal expansion of  CD8+ T cells in Alzheimer’s disease  progression1, 2. 
profiling of individuals who are under home care to track disease progression and therapeutic response, such as 
transplant patients and people under quarantine, and 3. tracking how stress, diet, and environmental conditions 
impact the immune system at short and long time scales, particularly in underrepresented populations who do 
not have easy access to hospitals or research institutions, such as people in rural or underdeveloped areas. Larger, 
more diverse subject pools coupled with time course studies of cell type gene expression in health and disease 
will have a dramatic impact on our ability to understand the baseline and variability of immune function.
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Figure 3.  Subject variability in immune and disease-relevant genes and pathways. (a) Magnitude  (log2 F 
statistic) of the variability in expression of genes between different cell types (x) and between subjects (y). 
1284/7034 (18.3%) of genes are above the subject specificity significance line (FDR < 0.05, multiple comparison 
correction) and are classified as subject-specific. Several MHC class II genes (HLA-X) are strongly subject-
specific, consistent with previous  findings35. (b) KEGG pathways grouped into categories and their enrichment 
(Z-score from 2-proportion Z-test) among the top 250 diurnally and subject-varying genes vs all genes. Immune 
system and disease pathways are significantly enriched (p = 0.029), supportive of the conclusion that immune 
and disease-related genes are highly subject dependent. The large circles indicate the enrichment of the category 
overall, and the sizes of the smaller pathway points indicate the number of genes associated with the pathway. 
(c) Subject and cell type specific gene examples for each subject and cell type with the upper row displaying the 
trace of mean gene expression across time-points and the bottom row showing gene abundance shifts for the 
subjects of interest.
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Online content
Online web portal is available to explore data presented in the main figures for study summary, diurnal and 
subject specific genes via https ://capbl ood-seq.calte ch.edu.
Methods
Human study cohort. This study was conducted at Caltech. Four healthy adults (2 male, 2 female) were 
recruited (Table S3). All participants provided written informed consent. The study was approved by the Insti-
tutional Review Board (IRB) at Caltech and all methods were performed in compliance with relevant guidelines 
and regulations. The blood collection took place in a non-BSL room to make sure the subjects were not exposed 
to pathogens. Subject blood was collected roughly 8 h apart over three consecutive days.
CPBMC isolation. 100 µl of capillary blood was collected via push-button collection device (TAP from Sev-
enth Sense Biosystems). For each blood draw, the site of collection was disinfected with an alcohol wipe and the 
TAP device was placed on the deltoid of the subject per device usage instructions. The button was pushed, and 
then blood was collected for 2–7 min until the indicator turned red. Blood was extracted from the TAP device 
by gently breaking the seal foil, and mixed with PBS + 2% FBS to 1 ml. The mixture was slowly added to the side 
of a SepMate tube (SepMate-15 IVD, Stem Cell Technologies) containing 4.5 ml of Lymphoprep (#07811, Stem 
Cell Technologies) and centrifuged for 20 min at 800 RPM. Approximately 900 µl of CPBMC layer was extracted 
below the plasma layer. To further remove red blood cells, 100  µl  of red blood cell lysis buffer (eBioscience 
10× RBC Lysis Buffer, #00-4300-54) was added to the CPBMCs and incubated at RT for 15 min. The CPBMC 
pellet was washed twice with PBS and centrifuged at 400 rpm for 5 min. Cells were counted using trypan blue 
via an automated detector (Countess II Automated Cell Counter) and subjects’ cells were pooled together for 
subsequent single-cell RNA sequencing.
Single-cell RNA sequencing. Subject pooled single-cell suspensions were loaded onto a Chromium Sin-
gle Cell Chip (10X Genomics) based on manufacturer’s instructions (targeted 10,000 cells per sample, 2500 cells 
per person per time point). Captured mRNA was barcoded during cDNA synthesis and pooled for Illumina 
sequencing (Chromium Single Cell 3′ solution—10X Genomics). Each time point was barcoded with a unique 
Illumina sample index, and then pooled together for sequencing in a single Illumina flow cell. The libraries were 
sequenced with an 8-base index read, 26-base read 1 containing cell-identifying barcodes and unique molecular 
identifiers (UMIs), and a 91-base read 2 containing transcript sequences on a NovaSeq 6000.
Single-cell dataset generation. FASTQ files from Illumina were demultiplexed and aligned using Cell 
Ranger v3.0 (https ://suppo rt.10xge nomic s.com/singl e-cell-gene-expre ssion /softw are/pipel ines/lates t/what-is-
cell-range r) and the hg19 reference genome with all options set to their defaults.
Sample demultiplexing. FASTQ files from the single-cell sequencing Illumina libraries were aligned 
against the hg19 (human) reference genome using Cellranger v3.0 count function. SNPs were detected in the 
aligned data using freebayes (https ://githu b.com/ekg/freeb ayes), which creates a combined variant call format 
(VCF) file, one per sample. SNPs were then grouped by cell barcode using popscle dsc-pileup (https ://githu 
b.com/statg en/popsc le). The SNP files for all samples were then merged into a single dsc-pileup file, and cell 
barcodes were disambiguated by providing a unique identifier per sample. Freemuxlet (popscle freemuxlet) was 
then run with default parameters to group cells into 4 subjects. This generates a probability of whether each cell 
barcode belongs to each subject, given the detection of single nucleotide polymorphism (SNPs) in reads associ-
ated with that cell barcode. Each cell was then assigned to the subject with the highest probability. Cells with low 
confidence (ambiguous cells) and high confidence in more than one subject (multiplets) were discarded, using 
popscle’s default confidence thresholds. See the README at https ://githu b.com/thoms onlab /capbl ood-seq for 
detailed instructions.
Debris removal. The raw cell gene matrix provided by Cell Ranger contains gene counts for all barcodes 
present in the data. To remove barcodes representing empty or debris-containing droplets, a debris removal step 
was performed. First, a UMI count threshold was determined that yielded more than the expected number of 
cells based on original cell counts (15,000). All barcodes below this threshold were discarded. For the remain-
ing barcodes, principal component analysis (PCA) was performed on the log-transformed cell gene matrix, and 
agglomerative clustering was used to cluster the cells. The number of clusters was automatically determined 
by minimizing the silhouette score among a range of numbers of clusters (6 to 15). For each cluster, a barcode 
dropoff trace was calculated by determining the number of barcodes remaining in the cluster for all thresholds in 
increments of 50. These cluster traces were then clustered into two clusters using agglomerative clustering—the 
two clusters representing “debris” with high barcode dropoff rates and “cells” with low barcode drop-off rates. All 
clusters categorized as “debris” were then removed from the data.
Gene filtering. Before cell typing, genes that have a maximum count less than 3 are discarded. Furthermore, 
after cell typing, any genes that are not present in at least 10% of one or more cell types are discarded.
Data normalization. Gene counts were normalized by dividing the number of times a particular gene 
appears in a cell (gene cell count) by the total gene counts in that cell. Furthermore, for visualization only, the 
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gene counts were multiplied by a constant factor (5000), and a constant value of 1 was added to avoid zeros and 
then log transformed.
Cell typing. We used single cell Variational Inference (scVI) to transform the raw cell gene expression data 
into a 10-dimensional variational autoencoder latent  space40. The variational autoencoder is conditioned on 
sample batch, creating a latent space which is independent of any batch-specific effects. The variational auto-
encoder parameters: learning rate = 1e−3, number of epochs = 50.
Agglomerative clustering (sci-kit learn) was used to generate clusters from the latent cell gene expression 
data. These clusters were then annotated based on known cell type marker genes (Fig. S1).
In order to resolve specific cell subtypes, such as those of T cells and Monocytes, we specified 13–15 clusters 
as an input for agglomerative clustering. For each study, we started at 13 clusters and incremented until all 4 
major cell types and 2 subtypes were separable. In cases where agglomerative clustering yielded multiple clusters 
of the same cell type, these clusters were merged into a single cell type for analysis.
Venous and capillary blood comparison. In order to compare venous blood cell type distributions to 
capillary blood, raw gene count data was downloaded from each of the respective studies, and we performed the 
same cell typing pipeline as for our capillary data, first projecting the data into a latent space via scVI, followed 
by agglomerative clustering and manual annotation based on known cell type marker genes.
Diurnal gene detection. To identify genes that exhibit diurnal variation in distinct cell types, we devel-
oped a statistical procedure that detects robust gene expression differences between morning (AM) and evening 
(PM) samples. Given that gene expression is different between subjects, we first normalize the mean gene expres-
sion within each subject for each cell type.
We take the mean gene expression μ for each gene gi in all samples k for cell type cn and subject sj and renor-
malize it into μ’ by subtracting the equally weighted mean of AM and PM samples (Eq. (1)). We then split the 
mean gene values into an AM group and a PM group and perform a statistical test (two-tailed student-t test) 
to determine whether to reject the null hypothesis that gene expression in AM and PM samples come from the 
same distribution. We then perform Benjamini–Hochberg multiple comparison correction at an FDR of 0.05 
on all gene and cell type p-values to determine where to plot the significance threshold. For plotting the genes, 
we choose the Z-statistic corresponding to the minimum p-value among cell types for that gene. To determine 
diurnality at the population level, we repeated the procedure above with all cells pooled into a single cell type.
Subject and cell type specific gene detection. To classify genes as subject specific, we detect genes 
with mean gene expression levels that are robustly different between subjects in at least one cell type. For each 
cell type cn and gene gi, we create subject groups containing the mean gene expression values from each sample. 
To determine whether the gene expression means from the different subjects do not originate from the same 
distribution, we perform an ANOVA one-way test to get an F-statistic and p-value for each gene. We then per-
form Benjamini–Hochberg multiple comparison correction at an FDR of 0.05 on all gene and cell type p-values. 
For plotting the genes, we chose the F-statistic corresponding to the minimum p-value among cell types for that 
gene.
For determining gene cell type specificity, we performed a similar procedure. In particular, for each gene gi, 
we create cell type groups containing the mean gene expression values for that cell type from each sample. We 
then perform a one-way ANOVA, and Benjamini–Hochberg multiple comparison correction at an FDR of 0.05.
Pathway enrichment analysis. Pathways from the KEGG database (python bioservices package) were 
used to calculate pathway enrichment for genes that were among the top 250 most diurnal and individual spe-
cific. All remaining genes present in the data were considered background. In order to normalize for gene pres-
ence across pathways, each gene was weighted by dividing the number of pathways in which that gene appears. 
For each KEGG  pathway41–43, the test statistic for a two-proportion z-test (python statsmodel v0.11.1) is used 
to determine pathway enrichment. From the top level pathway classes, we broke out “Diseases” into “Other”, 
“Immune Diseases”, and “Infectious Diseases” and separated “Immune System” from “Organismal System” to 
understand diurnal and subject-specific genes in an immune relevant context.
Figure art. All drawings (Figs. 1a,b, S2a) are generated using BioRender.com. Figure 1e was generated using 
GraphPad Prism 8.3.1.
Data availability
Gene expression matrix and relevant metadata are available on https ://data.calte ch.edu/recor ds/1407. FASTQ 
files are not being released to protect the identity of the subjects.
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Code availability
Custom code made for diurnal and subject specific gene detection is available on https ://githu b.com/thoms 
onlab /capbl ood-seq.
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